Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence

Evidence of Heavy Methylation in the Galectin 3 Promoter in Early Stages of Prostate Adenocarcinoma: Development and Validation of a Methylated Marker for Early Diagnosis of Prostate Cancer

(2014) Hafiz Ahmed et al.   Translational Oncology

Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin

(2011) Tsutomu Kobayashi et al.   INTERNATIONAL JOURNAL OF CANCER

Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma

(2011) Min Kyu Kim et al.   International Journal of Clinical Oncology

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease

(2010) Axel Heidenreich et al.   EUROPEAN UROLOGY

Galectin-3 is a substrate for prostate specific antigen (PSA) in human seminal plasma

(2010) Sarika Saraswati et al.   PROSTATE

Co-purification of Mac-2 binding protein with galectin-3 and association with prostasomes in human semen

(2010) Ashley S. Block et al.   PROSTATE

Galectin-3 expression is associated with bladder cancer progression and clinical outcome

(2010) Giacomo Canesin et al.   TUMOR BIOLOGY

Galectin-Expression an urologischen Tumoren

(2010) S. Waalkes et al.   UROLOGE

Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients

(2009) Pierre Vereecken et al.   MELANOMA RESEARCH

Tumor targeting and SPECT imaging properties of an 111In-labeled galectin-3 binding peptide in prostate carcinoma

(2009) Susan L. Deutscher et al.   NUCLEAR MEDICINE AND BIOLOGY

The construction of high-density paraffin tissue microarrays with 0.43-mm-diameter paraffin tissue core biopsies is technically feasible

(2008) Ulrich F. Vogel   VIRCHOWS ARCHIV

Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival

(2008) Axel S. Merseburger et al.   WORLD JOURNAL OF UROLOGY